Ibotta Inc has a consensus price target of $73.45 based on the ratings of 11 analysts. The high is $114 issued by Evercore ISI Group on August 14, 2024. The low is $44 issued by Citigroup on February 27, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, Citizens Capital Markets, and Citigroup on April 14, 2025, March 10, 2025, and February 27, 2025, respectively. With an average price target of $50.67 between Goldman Sachs, Citizens Capital Markets, and Citigroup, there's an implied 10.94% upside for Ibotta Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/14/2025 | Buy Now | 9.48% | Goldman Sachs | Eric Sheridan79% | $56 → $50 | Maintains | Buy | Get Alert |
03/10/2025 | Buy Now | 27% | Citizens Capital Markets | Andrew Boone73% | $58 → $58 | Reiterates | Market Outperform → Market Outperform | Get Alert |
02/27/2025 | Buy Now | -3.66% | Citigroup | Ronald Josey70% | $82 → $44 | Downgrade | Buy → Neutral | Get Alert |
02/27/2025 | Buy Now | 13.86% | Wells Fargo | Ken Gawrelski66% | $86 → $52 | Maintains | Overweight | Get Alert |
02/27/2025 | Buy Now | 22.62% | Goldman Sachs | Eric Sheridan79% | $85 → $56 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | 31.38% | Needham | Bernie McTernan61% | $80 → $60 | Maintains | Buy | Get Alert |
01/27/2025 | Buy Now | 86.12% | JMP Securities | Aaron Kimson44% | $85 → $85 | Reiterates | Market Outperform → Market Outperform | Get Alert |
11/14/2024 | Buy Now | 86.12% | JMP Securities | Andrew Boone73% | $111 → $85 | Maintains | Market Outperform | Get Alert |
11/14/2024 | Buy Now | 88.31% | Wells Fargo | Ken Gawrelski66% | $95 → $86 | Maintains | Overweight | Get Alert |
11/14/2024 | Buy Now | 42.33% | UBS | Chris Kuntarich52% | $90 → $65 | Downgrade | Buy → Neutral | Get Alert |
11/14/2024 | Buy Now | 75.17% | Needham | Bernie McTernan61% | $100 → $80 | Maintains | Buy | Get Alert |
10/29/2024 | Buy Now | 86.12% | Raymond James | Andrew Marok60% | $75 → $85 | Maintains | Outperform | Get Alert |
10/28/2024 | Buy Now | 108.01% | Wells Fargo | Ken Gawrelski66% | $85 → $95 | Maintains | Overweight | Get Alert |
10/14/2024 | Buy Now | 90.5% | Goldman Sachs | Eric Sheridan79% | $87 → $87 | Upgrade | Neutral → Buy | Get Alert |
08/14/2024 | Buy Now | 143.05% | JMP Securities | Andrew Boone73% | $130 → $111 | Maintains | Market Outperform | Get Alert |
08/14/2024 | Buy Now | 64.22% | Raymond James | Andrew Marok60% | $90 → $75 | Maintains | Outperform | Get Alert |
08/14/2024 | Buy Now | 90.5% | Goldman Sachs | Eric Sheridan79% | $103 → $87 | Maintains | Neutral | Get Alert |
08/14/2024 | Buy Now | 108.01% | Citigroup | Ronald Josey70% | $125 → $95 | Maintains | Buy | Get Alert |
08/14/2024 | Buy Now | 86.12% | Wells Fargo | Ken Gawrelski66% | $105 → $85 | Maintains | Overweight | Get Alert |
08/14/2024 | Buy Now | 149.62% | Evercore ISI Group | Mark Mahaney80% | $125 → $114 | Maintains | Outperform | Get Alert |
08/14/2024 | Buy Now | 140.86% | B of A Securities | Curtis Nagle48% | $118 → $110 | Maintains | Buy | Get Alert |
08/14/2024 | Buy Now | 118.96% | Needham | Bernie McTernan61% | $125 → $100 | Maintains | Buy | Get Alert |
07/08/2024 | Buy Now | 129.91% | Wells Fargo | Ken Gawrelski66% | $131 → $105 | Maintains | Overweight | Get Alert |
05/31/2024 | Buy Now | 182.46% | UBS | Chris Kuntarich52% | $125 → $129 | Maintains | Buy | Get Alert |
05/31/2024 | Buy Now | 184.65% | JMP Securities | Andrew Boone73% | $130 → $130 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/31/2024 | Buy Now | 173.7% | Needham | Bernie McTernan61% | $125 → $125 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 162.75% | Citigroup | Ronald Josey70% | → $120 | Initiates | → Buy | Get Alert |
05/13/2024 | Buy Now | 173.7% | UBS | Chris Kuntarich52% | → $125 | Initiates | → Buy | Get Alert |
05/13/2024 | Buy Now | 184.65% | JMP Securities | Andrew Boone73% | → $130 | Initiates | → Market Outperform | Get Alert |
05/13/2024 | Buy Now | 186.84% | Wells Fargo | Ken Gawrelski66% | → $131 | Initiates | → Overweight | Get Alert |
05/13/2024 | Buy Now | 173.7% | Raymond James | Andrew Marok60% | → $125 | Initiates | → Outperform | Get Alert |
05/13/2024 | Buy Now | 173.7% | Evercore ISI Group | Mark Mahaney80% | → $125 | Initiates | → Outperform | Get Alert |
05/13/2024 | Buy Now | 173.7% | Needham | Bernie McTernan61% | → $125 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 156.19% | B of A Securities | Curtis Nagle48% | → $117 | Initiates | → Buy | Get Alert |
05/13/2024 | Buy Now | 125.53% | Goldman Sachs | Eric Sheridan79% | → $103 | Initiates | → Neutral | Get Alert |
The latest price target for Ibotta (NYSE:IBTA) was reported by Goldman Sachs on April 14, 2025. The analyst firm set a price target for $50.00 expecting IBTA to rise to within 12 months (a possible 9.48% upside). 35 analyst firms have reported ratings in the last year.
The latest analyst rating for Ibotta (NYSE:IBTA) was provided by Goldman Sachs, and Ibotta maintained their buy rating.
The last upgrade for Ibotta Inc happened on October 14, 2024 when Goldman Sachs raised their price target to $87. Goldman Sachs previously had a neutral for Ibotta Inc.
The last downgrade for Ibotta Inc happened on February 27, 2025 when Citigroup changed their price target from $82 to $44 for Ibotta Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ibotta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ibotta was filed on April 14, 2025 so you should expect the next rating to be made available sometime around April 14, 2026.
While ratings are subjective and will change, the latest Ibotta (IBTA) rating was a maintained with a price target of $56.00 to $50.00. The current price Ibotta (IBTA) is trading at is $45.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.